Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN107973796B details a high-yield preparation of tadalafil isomers via racemization and total synthesis, offering cost reduction in API manufacturing and supply chain reliability.
Advanced synthesis of Mitiglinide intermediate via CDI activation. High-purity process ensuring cost reduction in API manufacturing and reliable supply chain continuity.
Patent CN111704636B reveals a high-yield method for aminoglycoside intermediates. Discover cost reduction in antibiotic manufacturing and scalable supply chain solutions.
Patent CN105294686B details a novel Riociguat preparation method offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102250080A details a scalable 4-step synthesis for Tebipenem intermediate V, eliminating chromatography to reduce cost and waste for pharmaceutical manufacturers.
Patent CN111233869B reveals a novel route for Remdesivir intermediates using masked pyrrolo-triazines, offering significant cost reduction and scalable manufacturing for global supply chains.
Novel palladium-catalyzed route for bilastine intermediates ensures high yield and safety. Reliable supplier for pharmaceutical manufacturing cost reduction.
Novel low-temperature oxidation route for pyrazine intermediates. Reduces steps and enhances supply chain reliability for pharmaceutical manufacturing.
Advanced synthesis of bendamustine intermediate via reductive alkylation. Superior purity >99.5% and optimized yield for reliable pharmaceutical supply chains.
Discover the patented 3-step synthesis for Latamoxef sodium 7-position side chain. Achieve high purity and cost reduction in API manufacturing with scalable methods.
Advanced synthesis of high-purity pyrazole boronic ester via diazotization and lithiation, offering cost-effective pharmaceutical intermediate solutions.
Patent CN101193888A details a novel 9-step PQQ synthesis. Achieve high purity and scalable production with improved isolation techniques for oxidoreductase cofactors.
Patent CN103467356A reveals a metal-free aqueous route for tetrahydroindoles, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN117701649B reveals enzymatic DKR for Brivaracetam intermediates. Achieve 99% ee and reduced costs. Reliable pharmaceutical intermediate supplier for scale-up.
Patent CN113816836A details enzymatic route for liver drug intermediate. High purity, scalable, cost-effective supply chain solution.
Patent CN107056695A details a novel Apatinib synthesis route offering higher purity and yield. This method reduces costs and simplifies supply chain for pharmaceutical manufacturing partners.
Patent CN112609202B enables green electrocatalytic synthesis of Xanthoisoxazoline B. Offers cost reduction and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN120718880A reveals high-efficiency biocatalysis for chiral amines. Achieve superior purity and reduced manufacturing costs with scalable enzyme technology.
Patent CN108948064A reveals a novel acetal-protected route for eribulin intermediates. Discover cost-effective, scalable manufacturing solutions for complex anticancer drug precursors.
Explore CN106317046B patent technology for anti-tumor intermediates. Discover cost-effective synthesis and reliable supply chain solutions for high-purity pharmaceutical compounds.